More than 200,000 customers worldwide have access to over 2,500 high-quality pharmaceutical raw materials thanks to Fagron’s global product and producer qualification, full analysis of incoming and produced products, GMP conditioning and release by a qualified person.
Fagron has sourcing offices in South America, North America, Europe and Asia. So Fagron can source its pharmaceutical raw materials globally while operating close to the production sites of pharmaceutical raw materials. This results in full traceability and a high standard of quality. On-site producer audits, (re)qualifications and regular performance assessments guarantee continuous control of Fagron’s product portfolio.
Fagron produces standardized products and products customized to specific customer needs, in a manufacturing network that includes its own production facilities and contract manufacturers on three continents, all meeting the latest national and international standards (GMP and GDP).
Quality control and product release
Securing that the pharmaceutical raw materials quality is in accordance with the latest editions of worldwide pharmacopoeias and that they are produced in factories which are GMP-compliant, is essential for Fagron to guarantee its high quality standards. Pharmaceutical raw materials are subjected to a rigorous process of tests. The results of these tests and the extensive range of documents Fagron demands from the producers, are reviewed by a qualified person before release.
Fagron Compounding Supplies Australia
Fagron Compounding Supplies Australia Pty. Ltd. is fully compliant with Australian code of good wholesaling practice for medicines in schedules 2, 3, 4 & 8 issued on the 13th of October, 2010 by the Therapeutic Goods Administration (TGA), a division of the Australian Department of Health.
Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS), and technical specifications are available for all our products online or upon request.